BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18771557)

  • 1. CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure.
    Vizzardi E; Nodari S; D'Aloia A; Chiari E; Faggiano P; Metra M; Dei Cas L
    Echocardiography; 2008 Oct; 25(9):955-60. PubMed ID: 18771557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of the myocardial performance index in ambulatory patients with heart failure: correlation with other clinical and echocardiographic parameters and independent prognostic value.
    Vizzardi E; Chiari E; Faggiano P; D'Aloia A; Bordonali T; Metra M; Cas LD
    Echocardiography; 2010 Feb; 27(2):123-9. PubMed ID: 19765064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One biologic marker (carbohydrate antigen-CA 125), two different diseases (ovarian cancer and congestive heart failure): practical implications of monitoring CA 125 serum levels. A case report.
    Faggiano P; D'Aloia A; Bignotti T; Dei Cas L
    Ital Heart J; 2003 Jul; 4(7):497-9. PubMed ID: 14558304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome.
    De Gennaro L; Brunetti ND; Bungaro R; Montrone D; Cuculo A; Pellegrino PL; Correale M; Di Biase M
    Coron Artery Dis; 2009 Jun; 20(4):274-80. PubMed ID: 19440066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the parameters derived from the relation between RR intervals and left ventricle performance with a history of heart failure in patients with atrial fibrillation.
    Lee WS; Lee KJ; Kim CJ
    Am J Cardiol; 2009 Oct; 104(7):959-65. PubMed ID: 19766764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-type natriuretic peptide and its relation to non-invasive indices of left ventricular function in patients with chronic heart failure.
    Del Ry S; Maltinti M; Cabiati M; Emdin M; Giannessi D; Morales MA
    Peptides; 2008 Jan; 29(1):79-82. PubMed ID: 18063200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine vasopressin levels are elevated and correlate with functional status in infants and children with congestive heart failure.
    Price JF; Towbin JA; Denfield SW; Clunie S; Smith EO; McMahon CJ; Radovancevic B; Dreyer WJ
    Circulation; 2004 Jun; 109(21):2550-3. PubMed ID: 15148276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prognostic index relating 24-hour ambulatory blood pressure to cardiac events in ischemic cardiomyopathy following defibrillator implantation.
    Antonini L; Colivicchi F; Pasceri V; Greco S; Varveri A; Turani L; Kol A; Santini M
    Pacing Clin Electrophysiol; 2008 Sep; 31(9):1089-94. PubMed ID: 18834457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour marker levels in patients with chronic heart failure.
    Varol E; Ozaydin M; Dogan A; Kosar F
    Eur J Heart Fail; 2005 Aug; 7(5):840-3. PubMed ID: 15916923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid--a marker for systemic inflammatory response in patients with congestive heart failure?
    Olexa P; Olexová M; Gonsorcík J; Tkác I; Kisel'ová J; Olejníková M
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):211-5. PubMed ID: 12238311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters.
    Kouris NT; Zacharos ID; Kontogianni DD; Goranitou GS; Sifaki MD; Grassos HE; Kalkandi EM; Babalis DK
    Eur J Heart Fail; 2005 Mar; 7(2):199-203. PubMed ID: 15701467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term systolic and diastolic ventricular performance after surgical ventricular restoration for dilated ischemic cardiomyopathy.
    Bové T; Van Belleghem Y; Vandenplas G; Caes F; François K; De Backer J; De Pauw M; Van Nooten G
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):995-1003; discussion 1003. PubMed ID: 19136274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial function assessed by real-time 3-dimensional echocardiography is related to right ventricular systolic pressure in chronic mitral regurgitation.
    Saraiva RM; Yamano T; Matsumura Y; Takasaki K; Toyono M; Agler DA; Greenberg N; Thomas JD; Shiota T
    Am Heart J; 2009 Aug; 158(2):309-16. PubMed ID: 19619710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure.
    Parekh N; Maisel AS
    Curr Opin Cardiol; 2009 Mar; 24(2):155-60. PubMed ID: 19532102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastolic dysfunction of the cardiac allograft and maximal exercise capacity.
    Roten L; Schmid JP; Merz F; Carrel T; Zwahlen M; Walpoth N; Mohacsi P; Hullin R
    J Heart Lung Transplant; 2009 May; 28(5):434-9. PubMed ID: 19416770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical ventricular restoration combined with mitral valve procedure for endstage ischemic cardiomyopathy.
    Suma H; Tanabe H; Uejima T; Isomura T; Horii T
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):280-4; discussion 284-5. PubMed ID: 19394851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of the treatment of the nodal reentrant tachycardia by RF catheter ablation on selected hemodynamic parameters of left ventricular systolic and diastolic function and exercise capacity].
    Lelakowski J; Dreher A
    Pol Merkur Lekarski; 2009 Jun; 26(156):600-4. PubMed ID: 19711724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.